IPP-PSP Block vs. SPSIPB in Breast Surgery

NCT ID: NCT07246720

Last Updated: 2025-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-15

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective, randomized clinical study aims to compare the analgesic efficacy of the interpectoral-pectoserratus plane block and the serratus posterior superior intercostal plane block for postoperative pain management in patients undergoing breast cancer surgery. Both techniques are ultrasound-guided regional anesthesia methods targeting different interfascial planes of the thoracic wall. The study will evaluate postoperative pain scores, opioid consumption, Quality of recovery and potential complications. The findings are expected to contribute to optimizing regional anesthesia strategies for enhanced recovery and improved analgesia following breast cancer surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Acute Pain Breast Cancer Regional Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group IPP-PSP

Interpectoral-Pectoserratus Plane Block

Group Type ACTIVE_COMPARATOR

Interpectoral-Pectoserratus Plane Block

Intervention Type PROCEDURE

Ultrasound-guided injection between pectoralis major-minor and pectoralis minor-serratus anterior planes.

Group SPSIPB

Serratus Posterior Superior Intercostal Plane Block

Group Type ACTIVE_COMPARATOR

Serratus Posterior Superior Intercostal Plane Block

Intervention Type PROCEDURE

Ultrasound-guided injection between the serratus posterior superior muscle and the intercostal muscles.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interpectoral-Pectoserratus Plane Block

Ultrasound-guided injection between pectoralis major-minor and pectoralis minor-serratus anterior planes.

Intervention Type PROCEDURE

Serratus Posterior Superior Intercostal Plane Block

Ultrasound-guided injection between the serratus posterior superior muscle and the intercostal muscles.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-65 years of age
* ASA I-II-III risk groups
* Patients with informed consent
* Patients undergoing breast cancer surgery

Exclusion Criteria

* ASA ≥ IV
* History of allergy to local anesthetics
* Known coagulation disorders
* Infection near the insertion site
* Chronic analgesic use
* Patients with diabetes mellitus and those receiving neoadjuvant chemotherapy (due to potential impairment of pain sensation)
* Body mass index \>30
* Dementia or confusion
* Lack of cooperation
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zonguldak Bulent Ecevit University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Çağdaş Baytar

medical doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zonguladk Bulent ecevit University

Zonguldak, Kozlu, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

çağdaş baytar, MD

Role: CONTACT

+905542255960

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hande aydemir, prof.dr

Role: primary

+90 372 261 23 00

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025/16-9

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.